Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol
2000

Isotretinoin Delivery via Inhalation in Rats

publication Evidence: moderate

Author Information

Author(s): Raleigh S M, Verschoyle R D, Bowskill C, Pastorino U, Staniforth J N, Steele F, Dinsdale D, Carthew P, Lim C K, Silvester J, Gescher A

Primary Institution: Medical Research Council Toxicology Unit, University of Leicester

Hypothesis

Can isotretinoin be effectively delivered to the lungs of rats through inhalation to minimize adverse effects associated with oral administration?

Conclusion

Inhalation of isotretinoin as a powder aerosol results in higher drug concentrations in the lungs compared to oral administration without significant tissue damage.

Supporting Evidence

  • Isotretinoin delivered by inhalation resulted in higher concentrations in the lungs compared to oral administration.
  • Repeated high doses via inhalation caused moderate weight loss but no significant tissue damage.

Takeaway

Giving isotretinoin through a spray to rats helps get more medicine into their lungs and causes less harm than taking it by mouth.

Methodology

Rats received isotretinoin either orally or by inhalation, and drug levels were measured in plasma and lung tissue using high-pressure liquid chromatography.

Limitations

The study was conducted on rats, and results may not directly translate to humans.

Participant Demographics

Rats were used in the study.

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1421

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication